Adaptation and validation into Spanish of schedule for the deficit syndrome;Adaptación y validación en castellano del inventario para la esquizofrenia deficitaria

Medicina Clinica

Volumn 129, Issue 3, 2007, Pages 91-93

  Bernardo, Miguel ^a,c   Fernández Egea, Emilio ^a   Torras, Amparo ^a   Gutiérrez, Fernando ^a   Ahuir, Maribel ^a   Arango, Celso ^b  

^a HOSPITAL CLÍNIC   (Spain)

^b HOSPITAL GENERAL UNIVERSITARIO GREGORIO MARAÑÓN   (Spain)

^c INSTITUT D INVESTIGACIONS BIOMÈDIQUES AUGUST PI I SUNYER IDIBAPS   (Spain)

Author keywords

Clinical guidelines; Deficit; Negative symptoms; Schizophrenia

Indexed keywords

ADULT; AGED; ARTICLE; CLINICAL ARTICLE; CLINICAL PROTOCOL; CONTROLLED STUDY; DISEASE COURSE; FEMALE; HUMAN; MALE; MEDICAL ASSESSMENT; METHODOLOGY; NEGATIVE SYNDROME; POSITIVE AND NEGATIVE SYNDROME SCALE; SCHEDULE FOR THE DEFICIT SYNDROME; SCHIZOPHRENIA; VALIDATION STUDY; CLASSIFICATION; LANGUAGE; QUESTIONNAIRE; SICKNESS IMPACT PROFILE;

ADULT; FEMALE; HUMANS; LANGUAGE; MALE; QUESTIONNAIRES; SCHIZOPHRENIA; SICKNESS IMPACT PROFILE;

EID: 34548399333     PISSN: 00257753     EISSN: 15788989     Source Type: Journal    
DOI: 10.1157/13107363     Document Type: Article

References (10)

1. Tunis SL, Ascher-Svanum H, Stensland M, Kinon BJ. Assessing the value of antipsychotics for treating schizophrenia: the importance of evaluating and interpreting the clinical significance of individual service costs. Pharmacoeconomics. 2004;22:1-8.
2. Hudson TJ, Sullivan G, Feng W, Owen RR, Thrush CR. Economic evaluations of novel antipsychotic medications: a literature review. Schizophr Res. 2003;60:199-218.
3. Milev P, Ho BC, Arndt S, Andreasen NC. Predictive values of neurocognition and negative symptoms on functional outcome in schizophrenia: a longitudinal first-episode study with 7-year follow-up. Am J Psychiatry. 2005;162:495-506.
4. Carpenter WT Jr, Heinrichs DW, Wagman AM. Deficit and nondeficit forms of schizophrenia: the concept. Am J Psychiatry. 1988;145:578-83.
5. Kirkpatrick B, Buchanan RW, Ross DE, Carpenter WT Jr. A separate disease within the syndrome of schizophrenia. Arch Gen Psychiatry. 2001;58:165-71.
6. Arango C, Kirkpatrick B, Buchanan RW, Carpenter WT Jr. The deficit syndrome: a domain of schizophrenia. Act Esp Psiquiatr. 1998;26:180-6.
7. Kirkpatrick B, Buchanan RW, McKenney PD, Alphs LD, Carpenter WT Jr. The Schedule for the deficit syndrome: an instrument for research in schizophrenia. Psychiatry Res. 1989;30:119-23.
8. Ribeyre JM, Dollfus S, Lesieur P, Menard JF, Petit M. Schedule for evaluation of the deficit syndrome in schizophrenia: Schedule for Deficit Syndrome (SDS) (Kirkpatrick et al). Importance pertinence of the SDS. Introduction of the French version. Encephale. 1994;20:413-9.
9. Lobo A, Chamorro L, Luque A, Dal-Re R, Badía X, Baró E, et al. Validación de las versiones en español de la Montgomery-Asberg Depression Rating Scale y la Hamilton Anxiety Rating Scale para la evaluación de la depresión y de la ansiedad. Med Clin (Barc). 2002;118:493-9.
10. Kimby D, Yale S, Goetz RR, McFarr LM, Malaspina D. The factorial structure of the Schedule for the Deficit Syndrome in schizophrenia. Schizophr Bull. 2006;32:274-8.